1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Pigmented Villonodular Synovitis: new trials by email Literature Review of Pigmented Villonodular Synovitis trials Research Report on Pigmented Villonodular Synovitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor Vimseltinib - Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis | Phase 1 / Phase 2 | Active not recruiting | Deciphera Pharmaceuticals, LLC | 120 | 2017-02-16 | 2026-06-25 |
| Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor FPA008 - Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor | Phase 1 / Phase 2 | Completed | Five Prime Therapeutics, Inc. | 66 | 2015-06-01 | 2021-08-31 |
Giant Cell Tumor of Tendon Sheath (2) · Synovitis, Pigmented Villonodular (2)
Giant Cell Tumors (2) · Joint Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Synovitis (2) · Tendinopathy (2)
cabiralizumab (1)
Deciphera Pharmaceuticals, LLC (1) · Five Prime Therapeutics, Inc. (1)
France (2) · Netherlands (2) · Poland (2) · United Kingdom (2) · United States (2) · Australia (1) · Canada (1) · Italy (1) · South Korea (1) · Spain (1)